Cargando…

Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection

Numerous canonical cellular signaling pathways modulate hepatitis B virus (HBV) replication. HBV genome products are known to play a significant role in regulating these cellular pathways for the liver’s viral-related pathology and physiology and have been identified as the main factor in hepatocarc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Yan, Qiu, Yuanwang, Davgadorj, Chantsalmaa, Zheng, Chunfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894711/ https://www.ncbi.nlm.nih.gov/pubmed/35252042 http://dx.doi.org/10.3389/fcimb.2022.847539

Ejemplares similares

Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection
por: Yan, Yan, et al.
Publicado: (2023)

Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study
por: Yan, Yan, et al.
Publicado: (2022)

Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes
por: Song, Zhihui, et al.
Publicado: (2023)

Metabolomics in viral hepatitis: advances and review
por: Yang, Jiajia, et al.
Publicado: (2023)

Serological and Molecular Characterization of Hepatitis B Virus Infection in Gastric Cancer
por: Li, Mengge, et al.
Publicado: (2022)

Role of Microbiota in Pathogenesis and Management of Viral Hepatitis
por: Sehgal, Rashi, et al.
Publicado: (2020)

Editorial: Viral Hepatitis: Pathophysiology, Prevention, and Control
por: Kao, Cheng, et al.
Publicado: (2021)

Alterations of the gut microbiota associated with the occurrence and progression of viral hepatitis
por: Yang, Xing, et al.
Publicado: (2023)

Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity
por: Zheng, Peiyu, et al.
Publicado: (2023)

Marmoset Viral Hepatic Inflammation Induced by Hepatitis C Virus Core Protein via IL-32
por: Liu, Bochao, et al.
Publicado: (2020)

Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles
por: Lim, Hong Kiat, et al.
Publicado: (2020)

Development and investigation of metabolism-associated risk assessment models for patients with viral hepatitis
por: Zhao, Mingjiu, et al.
Publicado: (2023)

The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018
por: Jia, Yuanyuan, et al.
Publicado: (2023)

Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target
por: Chen, Yunqing, et al.
Publicado: (2022)

NF-κB signaling pathway mechanism in cow intertoe skin inflammation caused by Fusobacterium necrophorum
por: Zhang, Hefei, et al.
Publicado: (2023)

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41
por: Yan, Hongxia, et al.
Publicado: (2022)

The Role of Non-coding RNAs in Viral Myocarditis
por: Zhang, Cong, et al.
Publicado: (2020)

Viral Haplotypes in COVID-19 Patients Associated With Prolonged Viral Shedding
por: Wu, Yingping, et al.
Publicado: (2021)

A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology
por: Yin, Xiaofeng, et al.
Publicado: (2022)

Roles of inflammasomes in viral myocarditis
por: Xu, Jingyu, et al.
Publicado: (2023)

A review of signal pathway induced by virulent protein CagA of Helicobacter pylori
por: Wang, Haiqiang, et al.
Publicado: (2023)

Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replication
por: Carter, Christoph C., et al.
Publicado: (2022)

EgGLUT1 Is Crucial for the Viability of Echinococcus granulosus sensu stricto Metacestode: A New Therapeutic Target?
por: Amahong, Kuerbannisha, et al.
Publicado: (2021)

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients
por: Zhao, Jing, et al.
Publicado: (2023)

Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
por: Yan, Fengna, et al.
Publicado: (2023)

Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
por: Liu, Jiachen, et al.
Publicado: (2021)

Clonorchis sinensis calcium-binding protein Cs16 causes acute hepatic injury possibly by reprogramming the metabolic pathway of bone marrow-derived monocytes
por: Li, Qi, et al.
Publicado: (2023)

Viral Apoptosis Evasion via the MAPK Pathway by Use of a Host Long Noncoding RNA
por: Barichievy, Samantha, et al.
Publicado: (2018)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

CVB3-Mediated Mitophagy Plays an Important Role in Viral Replication via Abrogation of Interferon Pathways
por: Oh, Soo-Jin, et al.
Publicado: (2021)

Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
por: du Plessis, Nelita, et al.
Publicado: (2018)

Role of Tau protein in long COVID and potential therapeutic targets
por: Marwaha, Bharat
Publicado: (2023)

Editorial: Unsolved challenges in hepatitis B and hepatitis C: from prevention to treatment
por: Yue, Ming
Publicado: (2023)

Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice
por: Zhu, Qingfeng, et al.
Publicado: (2019)

Corrigendum: CVB3-Mediated Mitophagy Plays an Important Role in Viral Replication via Abrogation of Interferon Pathways
por: Oh, Soo-Jin, et al.
Publicado: (2021)

Notch Signaling Pathway Is Activated by Sulfate Reducing Bacteria
por: Singh, Sudha B., et al.
Publicado: (2021)

Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection
por: Silwal, Prashanta, et al.
Publicado: (2021)

Dpep2 Emerging as a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis
por: Yang, Xiaoli, et al.
Publicado: (2019)

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China
por: Chen, Yunbo, et al.
Publicado: (2022)

Corrigendum: Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice
por: Zhu, Qingfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e2d9fkkjo27dehmsf6fakvenj3